Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of  personal privacy.

*Name of Committee:*                         National Institute of Arthritis and Musculoskeletal and Skin Diseases Special Emphasis Panel;  Career Development, Research Training & Pathways to Independence Review.                    

*Date:*                         November 3, 2009.                    

*Time:*                         11 a.m. to 1 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health,  One Democracy Plaza,  6701 Democracy Boulevard,  Bethesda, MD 20892,  (Telephone Conference Call).                    

*Contact Person:*                         Charles H Washabaugh, PhD,  Scientific Review Officer,  National Institute of Arthritis,  Musculoskeletal and Skin Diseases,  National Institutes of Health,  6701 Democracy Boulevard Suite 800,  Bethesda, MD 20892,  301-594-4952,                         *washabac@mail.nih.gov.*

*Name of Committee:*                         National Institute of Arthritis and Musculoskeletal and Skin Diseases Special Emphasis Panel; Ancillary Clinical Studies.                     

*Date:*                         November 12, 2009.                    

*Time:*                         9 a.m. to 12 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health,  One Democracy Plaza,  6701 Democracy Boulevard,  Bethesda, MD 20892,  (Virtual Meeting).                    

*Contact Person:*                         Charles H Washabaugh, PhD,  Scientific Review Officer,  6701 Democracy Blvd, Suite 800,   National Institute of Arthritis, Musculoskeletal  and Skin Diseases,National Institutes of Health,  Bethesda, MD 20892,  (301) 594-4952,                         *washabac@mail.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.846, Arthritis, Musculoskeletal and Skin Diseases  Research, National Institutes of Health, HHS)

Dated: October 14, 2009.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. E9-25411 Filed 10-21-09; 8:45 am]

BILLING CODE 4140-01-P